35182691|t|A53T alpha-synuclein induces neurogenesis impairment and cognitive dysfunction in line M83 transgenic mice and reduces the proliferation of embryonic neural stem cells.
35182691|a|Dementia with Lewy body (DLB) is the second most common degenerative dementia after Alzheimer's disease. There is no therapeutic drug for DLB currently. It's urgent for us to understand the pathological mechanism of dementia mediated by alpha-synuclein, as the main component of Lewy body. Here, we found that the A53T alpha-synuclein transgenic mice showed decreased nesting behavior starting from the age of 1 month. The results in Morris water maze test suggested that the 6-month-old mice had learning memory deficits. Golgi staining indicated that the apical neuronal dendritic spines of hippocampal CA1 neurons were significantly reduced in 6-month-old homozygotes and heterozygotes, although MAP2 protein expression revealed no significant difference in the hippocampus among wild-type mice, homozygotes and heterozygotes. In vitro, we proved mutant A53T alpha-synuclein decreased the dendritic branches and dendrite spines on the embryonic mice hippocampal neurons. Furthermore, Ki67 immunofluorescence staining identified that the Ki67-positive cells of the hippocampal dentate gyrus and subventricular zone were significantly reduced in 6-month-old homozygotes and heterozygotes, compared with age-matched wild-type mice. Similarly, when 6-month-old mice were injected with BrdU for one day, the immunostaining results also confirmed that BrdU-positive cells were significantly reduced in homozygous and heterozygous mice. Lastly, we transfected primary embryonic hippocampal neural stem cells with lentivirus vector expressing A53T alpha-synuclein in vitro. Both BrdU staining and Western blotting showed that A53T alpha-synuclein significantly decreased the proliferation of embryonic neural stem cells. Taken together, these data suggest that A53T alpha-synuclein can induce adult neurogenesis impairment and cognitive dysfunction. The A53T alpha-synuclein transgenic mice may be used as an animal model for DLB. Promoting adult neurogenesis may be a promising approach to treat DLB pathogenesis.
35182691	0	4	A53T	ProteinMutation	tmVar:p|SUB|A|53|T;HGVS:p.A53T;VariantGroup:0;OriginalGene:20617;CorrespondingGene:6622;RS#:104893877;CorrespondingSpecies:10090;CA#:257068
35182691	5	20	alpha-synuclein	Gene	20617
35182691	29	52	neurogenesis impairment	Disease	MESH:D001750
35182691	57	78	cognitive dysfunction	Disease	MESH:D003072
35182691	102	106	mice	Species	10090
35182691	169	192	Dementia with Lewy body	Disease	MESH:D020961
35182691	194	197	DLB	Disease	MESH:D020961
35182691	225	246	degenerative dementia	Disease	MESH:D000544
35182691	253	272	Alzheimer's disease	Disease	MESH:D000544
35182691	307	310	DLB	Disease	MESH:D020961
35182691	385	393	dementia	Disease	MESH:D003704
35182691	406	421	alpha-synuclein	Gene	20617
35182691	448	457	Lewy body	Disease	MESH:D020961
35182691	483	487	A53T	ProteinMutation	tmVar:p|SUB|A|53|T;HGVS:p.A53T;VariantGroup:0;OriginalGene:20617;CorrespondingGene:6622;RS#:104893877;CorrespondingSpecies:10090;CA#:257068
35182691	488	503	alpha-synuclein	Gene	20617
35182691	515	519	mice	Species	10090
35182691	657	661	mice	Species	10090
35182691	666	690	learning memory deficits	Disease	MESH:D007859
35182691	868	872	MAP2	Gene	17756
35182691	962	966	mice	Species	10090
35182691	1026	1030	A53T	ProteinMutation	tmVar:p|SUB|A|53|T;HGVS:p.A53T;VariantGroup:0;OriginalGene:20617;CorrespondingGene:6622;RS#:104893877;CorrespondingSpecies:10090;CA#:257068
35182691	1031	1046	alpha-synuclein	Gene	20617
35182691	1117	1121	mice	Species	10090
35182691	1156	1160	Ki67	Gene	17345
35182691	1209	1213	Ki67	Gene	17345
35182691	1395	1399	mice	Species	10090
35182691	1429	1433	mice	Species	10090
35182691	1453	1457	BrdU	Chemical	MESH:D001973
35182691	1518	1522	BrdU	Chemical	MESH:D001973
35182691	1596	1600	mice	Species	10090
35182691	1707	1711	A53T	ProteinMutation	tmVar:p|SUB|A|53|T;HGVS:p.A53T;VariantGroup:0;OriginalGene:20617;CorrespondingGene:6622;RS#:104893877;CorrespondingSpecies:10090;CA#:257068
35182691	1712	1727	alpha-synuclein	Gene	20617
35182691	1743	1747	BrdU	Chemical	MESH:D001973
35182691	1790	1794	A53T	ProteinMutation	tmVar:p|SUB|A|53|T;HGVS:p.A53T;VariantGroup:0;OriginalGene:20617;CorrespondingGene:6622;RS#:104893877;CorrespondingSpecies:10090;CA#:257068
35182691	1795	1810	alpha-synuclein	Gene	20617
35182691	1925	1929	A53T	ProteinMutation	tmVar:p|SUB|A|53|T;HGVS:p.A53T;VariantGroup:0;OriginalGene:20617;CorrespondingGene:6622;RS#:104893877;CorrespondingSpecies:10090;CA#:257068
35182691	1930	1945	alpha-synuclein	Gene	20617
35182691	1963	1986	neurogenesis impairment	Disease	MESH:D001750
35182691	1991	2012	cognitive dysfunction	Disease	MESH:D003072
35182691	2018	2022	A53T	ProteinMutation	tmVar:p|SUB|A|53|T;HGVS:p.A53T;VariantGroup:0;OriginalGene:20617;CorrespondingGene:6622;RS#:104893877;CorrespondingSpecies:10090;CA#:257068
35182691	2023	2038	alpha-synuclein	Gene	20617
35182691	2050	2054	mice	Species	10090
35182691	2090	2093	DLB	Disease	MESH:D020961
35182691	2161	2164	DLB	Disease	MESH:D020961
35182691	Positive_Correlation	MESH:D020961	RS#:104893877;HGVS:p.A53T;CorrespondingGene:6622
35182691	Positive_Correlation	MESH:D007859	RS#:104893877;HGVS:p.A53T;CorrespondingGene:6622
35182691	Positive_Correlation	MESH:D003072	RS#:104893877;HGVS:p.A53T;CorrespondingGene:6622
35182691	Positive_Correlation	MESH:D001750	RS#:104893877;HGVS:p.A53T;CorrespondingGene:6622
35182691	Association	MESH:D003072	20617
35182691	Association	MESH:D007859	20617
35182691	Association	MESH:D020961	20617
35182691	Positive_Correlation	MESH:D001750	20617
35182691	Association	MESH:D003704	20617
35182691	Association	MESH:D020961	6622
35182691	Association	MESH:D007859	6622
35182691	Association	MESH:D003072	6622
35182691	Association	MESH:D001750	6622

